The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Thymoquinone: Potential cure for inflammatory disorders and cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Antitumor Activity of Gemcitabine and Oxaliplatin Is Augmented by Thymoquinone in Pancreatic Cancer
Banerjee, S., Kaseb, A. O., Wang, Z., Kong, D., Mohammad, M., Padhye, S., Sarkar, F. H., & Mohammad, R. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4235 · Cited by 244
RetractedRavindran, J., Nair, H. B. B., Sung, B., Prasad, S., TEKMAL, R. R., & Aggarwal, B. B. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.01.023 · Cited by 138
RetractedTekeoğlu, İ., Doğan, A., & Demiralp, L. (2006) · Phytotherapy Research · doi:10.1002/ptr.1964 · Cited by 47
RetractedImmunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Oxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441
Global cancer statistics in the year 2000
Parkin, D. M. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(01)00486-7 · Cited by 2,445
Antioxidant activity of Nigella sativa essential oil
Burits, M., & Bucar, F. (2000) · Phytotherapy Research · doi:10.1002/1099-1573(200008)14:5<323::aid-ptr621>3.0.co;2-q · Cited by 1,857
Role of Quinones in Toxicology
Bolton, J. L., Trush, M. A., Penning, T. M., Dryhurst, G., & Monks, T. J. (2000) · Chemical Research in Toxicology · doi:10.1021/tx9902082 · Cited by 1,703
The changing faces of glutathione, a cellular protagonist
Pompella, A., Visvikis, A., Paolicchi, A., Tata, V. D., & Casini, A. F. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00504-5 · Cited by 1,359
Transcription factors as targets for cancer therapy
Darnell, J. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc906 · Cited by 1,194 · cited 1×
“STAT3 is often constitutively activated in various carcinomas and interferes at different levels of tumorigenesis [36].”
BackgroundChronic inflammation: importance of NOD2 and NALP3 in interleukin-1β generation
Ferrero-Miliani, L., Nielsen, O. H., Andersen, P. S., & Girardin, S. E. (2007) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2006.03261.x · Cited by 1,079
Cell cycle kinases as therapeutic targets for cancer
Lapenna, S., & Giordano, A. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2907 · Cited by 905
Natural products in cancer chemotherapy: past, present and future
Mann, J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc723 · Cited by 684
(2008) · Arthritis & Rheumatism · doi:10.1002/art.23363 · Cited by 505
Thymoquinone Is a Potent Superoxide Anion Scavenger
Badary, O. A., Taha, R. A., Gamal El-Din, A. M., & Abdel-Wahab, M. H. (2003) · Drug and Chemical Toxicology · doi:10.1081/dct-120020404 · Cited by 447
Transcription Factor NF‐κB: A Sensor for Smoke and Stress Signals
AHN, K. S., & AGGARWAL, B. B. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1352.026 · Cited by 432
Thymoquinone: A promising anti-cancer drug from natural sources
Gali-Muhtasib, H., Roessner, A., & Schneider-Stock, R. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.10.009 · Cited by 420
STAT3 SIGNALING: Anticancer Strategies and Challenges
Johnston, P. A., & Grandis, J. R. (2011) · Molecular Interventions · doi:10.1124/mi.11.1.4 · Cited by 406
Joosten, L. A. B., Helsen, M. M. A., van de Loo, F. A. J., & van den Berg, W. B. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390513 · Cited by 400
Black cumin seed essential oil, as a potent analgesic and antiinflammatory drug
Hajhashemi, V., Ghannadi, A., & Jafarabadi, H. (2004) · Phytotherapy Research · doi:10.1002/ptr.1390 · Cited by 365
Yi, T., Cho, S.-G., Yi, Z., Pang, X., Rodriguez, M., Wang, Y., Sethi, G., Aggarwal, B. B., & Liu, M. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0124 · Cited by 352
Self-citationCytokines as a key component of cancer-related inflammation
Germano, G., Allavena, P., & Mantovani, A. (2008) · Cytokine · doi:10.1016/j.cyto.2008.07.014 · Cited by 331
Mansour, M. A., Nagi, M. N., El‐Khatib, A. S., & Al‐Bekairi, A. M. (2002) · Cell Biochemistry and Function · doi:10.1002/cbf.968 · Cited by 330
Sethi, G., Ahn, K. S., & Aggarwal, B. B. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2088 · Cited by 316
Self-citationChehl, N., Chipitsyna, G., Gong, Q., Yeo, C. J., & Arafat, H. A. (2009) · HPB · doi:10.1111/j.1477-2574.2009.00059.x · Cited by 315
El‐Mahdy, M. A., Zhu, Q., Wang, Q., Wani, G., & Wani, A. A. (2005) · International Journal of Cancer · doi:10.1002/ijc.21205 · Cited by 288
Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo
Jafri, S. H., Glass, J., Shi, R., Zhang, S., Prince, M., & Kleiner-Hancock, H. (2010) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-29-87 · Cited by 238
Cisplatin Overdose: Toxicities and Management
Tsang, R. Y., Al-Fayea, T., & Au, H.-J. (2009) · Drug Safety · doi:10.2165/11316640-000000000-00000 · Cited by 235
Androgen Receptor– and E2F-1–Targeted Thymoquinone Therapy for Hormone-Refractory Prostate Cancer
Kaseb, A. O., Chinnakannu, K., Chen, D., Sivanandam, A., Tejwani, S., Menon, M., Dou, Q. P., & Reddy, G. P.-V. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1483 · Cited by 231
Badary, O. A., Nagi, M. N., Al-Shabanah, O. A., Al-Sawaf, H. A., Al-Sohaibani, M. O., & Al-Bekairi, A. M. (1997) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-75-12-1356 · Cited by 230
Anticancer activity of thymoquinone in breast cancer cells: Possible involvement of PPAR-γ pathway
Woo, C. C., Loo, S. Y., Gee, V., Yap, C. W., Sethi, G., Kumar, A. P., & Benny Tan, K. H. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.05.030 · Cited by 227
Self-citationAnti-inflammatory effect of thymoquinone in a mouse model of allergic lung inflammation
El Gazzar, M., El Mezayen, R., Marecki, J. C., Nicolls, M. R., Canastar, A., & Dreskin, S. C. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.02.004 · Cited by 225
Cragg, G. M. L. (1998) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199809)18:5<315::aid-med3>3.0.co;2-w · Cited by 223
Arafa, E.-S. A., Zhu, Q., Shah, Z. I., Wani, G., Barakat, B. M., Racoma, I., El-Mahdy, M. A., & Wani, A. A. (2011) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2010.10.007 · Cited by 210
Roepke, M., Diestel, A., Bajbouj, K., Walluscheck, D., Schonfeld, P., Roessner, A., Schneider-Stock, R., & Gali-Muhtasib, H. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.2.3575 · Cited by 206
Abdelmeguid, N. E., Fakhoury, R., KAMAL, S. M., & Wafai, R. J. A. (2010) · Journal of Diabetes · doi:10.1111/j.1753-0407.2010.00091.x · Cited by 198
Effects of thymoquinone (volatile oil of black cumin) on rheumatoid arthritis in rat models
Tekeoglu, I., Dogan, A., Ediz, L., Budancamanak, M., & Demirel, A. (2007) · Phytotherapy Research · doi:10.1002/ptr.2143 · Cited by 198
Gali-Muhtasib, H. U., Abou Kheir, W. G., Kheir, L. A., Darwiche, N., & Crooks, P. A. (2004) · Anti-Cancer Drugs · doi:10.1097/00001813-200404000-00012 · Cited by 187
Badary, O. A. (1999) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(98)00242-6 · Cited by 180
Gali‐Muhtasib, H., Ocker, M., Kuester, D., Krueger, S., El‐Hajj, Z., Diestel, A., Evert, M., El‐Najjar, N., Peters, B., Jurjus, A., et al. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00095.x · Cited by 178
Li, F., Rajendran, P., & Sethi, G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00874.x · Cited by 176
Self-citationThymoquinone Induces Telomere Shortening, DNA Damage and Apoptosis in Human Glioblastoma Cells
Gurung, R. L., Lim, S. N., Khaw, A. K., Soon, J. F. F., Shenoy, K., Mohamed Ali, S., Jayapal, M., Sethu, S., Baskar, R., & Hande, M. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012124 · Cited by 176
Gali-Muhtasib, H., Kuester, D., Mawrin, C., Bajbouj, K., Diestel, A., Ocker, M., Habold, C., Foltzer-Jourdainne, C., Schoenfeld, P., Peters, B., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0884 · Cited by 170
Elmezayen, R., Gazzar, M. E., Nicolls, M. R., Marecki, J. C., Dreskin, S. C., & Nomiyama, H. (2006) · Immunology Letters · doi:10.1016/j.imlet.2006.04.012 · Cited by 169
Sayed-Ahmed, M. M., Aleisa, A. M., Al-Rejaie, S. S., Al-Yahya, A. A., Al-Shabanah, O. A., Hafez, M. M., & Nagi, M. N. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.4.12714 · Cited by 167
Combinatorial effects of thymoquinone on the anti-cancer activity of doxorubicin
Effenberger‐Neidnicht, K., & Schobert, R. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1386-x · Cited by 155
Inhibition of 5-lipoxygenase and Leukotriene C4Synthase in Human Blood Cells by Thymoquinone
Mansour, M. A., & Tornhamre, S. (2004) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756360400002072 · Cited by 154
Torres, M. P., Ponnusamy, M. P., Chakraborty, S., Smith, L. M., Das, S., Arafat, H. A., & Batra, S. K. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0075 · Cited by 149
Koka, P. S., Mondal, D., Schultz, M., Abdel‐Mageed, A. B., & Agrawal, K. C. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2010.009369 · Cited by 147
In vitro toxicological properties of thymoquinone
Khader, M., Bresgen, N., & Eckl, P. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2008.10.019 · Cited by 145
Vaillancourt, F., Silva, P. J., Shi, Q., Fahmi, H., Fernandes, J., & Benderdour, M. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22884 · Cited by 145
Alhosin, M., Abusnina, A., Achour, M., Sharif, T., Muller, C. D., Peluso, J., Chataigneau, T., Lugnier, C., Schini‐Kerth, V. B., Bronner, C., et al. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.12.015 · Cited by 144
Kanter, M. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9419-5 · Cited by 126
Nagi, M. N., & Almakki, H. A. (2009) · Phytotherapy Research · doi:10.1002/ptr.2766 · Cited by 114
Ng, W. K., Yazan, L. S., & Ismail, M. (2011) · Toxicology in Vitro · doi:10.1016/j.tiv.2011.04.030 · Cited by 109
Hussain, A. R., Ahmed, M., Ahmed, S. O., Manogaran, P. S., Platanias, L. C., Alvi, S. N., Al-Kuraya, K. S., & Shahab Uddin, M. S. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.034 · Cited by 108
Sankaranarayanan, C., & Pari, L. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.02.029 · Cited by 102
Ganea, G. M., Fakayode, S. O., Losso, J. N., van Nostrum, C. F., Sabliov, C. M., & Warner, I. M. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/28/285104 · Cited by 96
Protective effects of thymoquinone against methotrexate-induced testicular injury
Gökçe, A., Oktar, S., Koc, A., & Yönden, Z. (2010) · Human & Experimental Toxicology · doi:10.1177/0960327110382564 · Cited by 92
The antitumor activity of thymoquinone and thymohydroquinone in vitro and in vivo.
Ivanković, S., Stojković, R., Jukic, M., et al. (2006) · PubMed · Cited by 90
Gazzar, M. A. E., Elmezayen, R., Nicolls, M. R., & Dreskin, S. C. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.01.002 · Cited by 88
Mohamed, A., Shoker, A., Bendjelloul, F., Mare, A., Alzrigh, M., Benghuzzi, H., & Desin, T. (2003) · PubMed · Cited by 88
El-Mahmoudy, A. M., Shimizu, Y., Shiina, T., Matsuyama, H., Elsayed, M., & Takewaki, T. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.09.001 · Cited by 74
Protective effects of thymoquinone on streptozotocin-induced diabetic nephropathy
Kanter, M. (2009) · Journal of Molecular Histology · doi:10.1007/s10735-009-9220-7 · Cited by 59
Radiosensitization in human breast carcinoma cells by thymoquinone: role of cell cycle and apoptosis
Velho‐Pereira, R., Kumar, A., Pandey, B. N., et al. (2011) · Cell Biology International · doi:10.1042/cbi20100701 · Cited by 57
Self-citationGazzar, M. A. E. (2007) · Inflammation Research · doi:10.1007/s00011-007-7051-0 · Cited by 56
Effects of thymoquinone on isolated and cellular proteasomes
Cecarini, V., Quassinti, L., Blasio, A. D., Bonfili, L., Bramucci, M., Lupidi, G., Cuccioloni, M., Mozzicafreddo, M., Angeletti, M., & Eleuteri, A. M. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07629.x · Cited by 53
Li, Q.-X., Yu, D., Liu, G., Ke, N., McKelvy, J. F., & Wong‐Staal, F. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.48 · Cited by 38
Richards, L. R., Jones, P., Hughes, J., Benghuzzi, H., & Tucci, M. A. (2006) · PubMed · Cited by 28
Cited by
Thymoquinone and its therapeutic potentials
Darakhshan, S., Bidmeshki Pour, A., Hosseinzadeh Colagar, A., & Sisakhtnezhad, S. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.03.011 · Cited by 507
Targeting autophagy using natural compounds for cancer prevention and therapy
Deng, S., Shanmugam, M. K., Kumar, A. P., Yap, C. T., Sethi, G., & Bishayee, A. (2019) · Cancer · doi:10.1002/cncr.31978 · Cited by 320
Self-citationAmin, B., & Hosseinzadeh, H. (2015) · Planta Medica · doi:10.1055/s-0035-1557838 · Cited by 276
Targeting transcription factor STAT3 for cancer prevention and therapy
Chai, E. Z. P., Shanmugam, M. K., Arfuso, F., Dharmarajan, A., Wang, C., Kumar, A. P., Samy, R. P., Lim, L. H. K., Wang, L., Goh, B. C., et al. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.10.004 · Cited by 263
Self-citationKaempferol, a potential cytostatic and cure for inflammatory disorders
Rajendran, P., Rengarajan, T., Nandakumar, N., Palaniswami, R., Nishigaki, Y., & Nishigaki, I. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.08.011 · Cited by 259
Metadata
- Authors
- Woo, C. C., Kumar, A. P., Sethi, G., & Tan, K. H. B.
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 2012-02
- Volume
- 83
- Issue
- 4
- Pages
- 443-451
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W2079621764
- Cited by
- 541
- References
- 69
- FWCI
- 68.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.